| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
David Kirske
Chief Financial Officer, Treasurer and Corporate Secretary
|
72 |
Since 2025
1 year
|
$4,599,266 | |
|
John Volpone
President and Chief Operating Officer
|
51 | Not stated | $6,667,487 | |
|
Adam R. Craig
Also a director
Executive Chairman and Director
|
60 | Not stated | $6,705,205 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Mar 20, 2026 · updated by the 8-K of Jul 1, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Adam R. Craig
Board chair
|
60 | Not stated | Not independent | None stated | Stratus Therapeutics | Not stated | |
|
Michael S. Wyzga
Lead independent director
|
71 | Not stated | Independent | None stated | GenSight Biologics S.A. | $89,147 | |
|
Gary J. Bridger
|
63 | Not stated | Independent | None stated | None stated | Not stated | |
|
Françoise De Craecker
|
64 |
2021
5 years
|
Independent | None stated | Gensight Biologics | $57,101 | |
|
Murray W. Stewart
|
65 |
2019
7 years
|
Independent | None stated | CAMP4 Therapeutics Corporation | $62,710 | |
|
Kelly Gold
Joined Jul 1, 2026
|
- | - | - |
Audit Committee
|
- | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Mar 20, 2026 states there were none.
Read it in the proxyLoading...